Korro Bio, Inc.KRRONASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-79.08M
↓ 87% vs avg
Percentile
P0
Near historical low
Streak
4 yr
Consecutive declineContracting
Average
$-42.25M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-79.08M | -1.4% |
| 2024 | $-77.98M | -3.8% |
| 2023 | $-75.12M | -27.6% |
| 2022 | $-58.86M | -61.1% |
| 2021 | $-36.54M | +29.5% |
| 2020 | $-51.86M | -256.4% |
| 2019 | $33.15M | +289.9% |
| 2018 | $-17.46M | -6.0% |
| 2017 | $-16.48M | - |